These results shed light on PFKFB3 and autophagy in affecting Oxa’s anti-tumor efficiency, and provide a theoretical basis regarding potential therapeutic targets and strategies for colon cancer. This evidence concerns the gene PFKFB3 and colonic neoplasm.